Andrew MBA - Adhera Therapeutics COO, Chairman
| ATRXDelisted Stock | USD 0.72 0.00 0.00% |
Chairman
Andrew MBA is COO, Chairman of Adhera Therapeutics
| Age | 42 |
| Phone | 919 518 3748 |
| Web | https://adherathera.com |
Adhera Therapeutics Management Efficiency
The company has return on total asset (ROA) of (4.484) % which means that it has lost $4.484 on every $100 spent on assets. This is way below average. Adhera Therapeutics' management efficiency ratios could be used to measure how well Adhera Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Adhera Therapeutics currently holds 7.35 M in liabilities with Debt to Equity (D/E) ratio of 56.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Adhera Therapeutics has a current ratio of 0.05, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Adhera Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Adhera Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Adhera Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Adhera to invest in growth at high rates of return. When we think about Adhera Therapeutics' use of debt, we should always consider it together with cash and equity.
Adhera Therapeutics, Inc. focuses on the discovery and development of drugs. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana. Adhera Therapeutics is traded on OTC Exchange in the United States. Adhera Therapeutics [ATRX] is a Pink Sheet which is traded between brokers over the counter. Adhera Therapeutics is listed under Pharmaceutical Products category by Fama And French industry classification. Management Performance
| Return On Asset | -4.48 |
Adhera Therapeutics Leadership Team
Elected by the shareholders, the Adhera Therapeutics' board of directors comprises two types of representatives: Adhera Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Adhera. The board's role is to monitor Adhera Therapeutics' management team and ensure that shareholders' interests are well served. Adhera Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Adhera Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Andrew MBA, COO, Chairman | ||
| BS BS, Chief CEO |
Adhera Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Adhera Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -4.48 | ||||
| Current Valuation | 10.55 M | ||||
| Shares Outstanding | 3.16 M | ||||
| Shares Owned By Insiders | 21.87 % | ||||
| Number Of Shares Shorted | 2.05 K | ||||
| Price To Earning | (125.83) X | ||||
| Price To Sales | 8.23 X | ||||
| Gross Profit | (157 K) | ||||
| EBITDA | (4.92 M) | ||||
| Net Income | (6.35 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in Adhera Pink Sheet
If you are still planning to invest in Adhera Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Adhera Therapeutics' history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |